Welcome to “Remember When Kids Just Died?” A daily two-part tour through every vaccine-preventable disease, starting with polio on September 1, 2026. Each disease gets two posts: the pre-vaccine era, when parents enjoyed the character-building experience of burying their children, and the post-vaccine era, when we ruined everything by making childhood survivable. Cramming both into one post felt disrespectful, to the corpses and the Nobel Prizes.

The Bug Nobody Talks About Because It Doesn’t Have a Cool Name

Pertussis got a nickname. Measles got a rash you can Instagram. Pneumococcus got… “pneumococcus.” Which is a shame, because Streptococcus pneumoniae spent the entire 20th century quietly out-killing most of the diseases parents actually worry about.

Before the year 2000, in American children younger than 5, pneumococcus caused roughly 17,000 cases of invasive disease a year, 13,000 cases of bacteremia, about 700 cases of meningitis, and around 200 deaths (CDC Pink Book). It also caused 5 million ear infections a year and drove more than 10 million pediatrician visits for middle-ear disease. By age 12 months, more than 60% of American children had already had at least one bout of otitis media.

Pneumococcus was basically running a Groupon on childhood suffering. And it wasn’t a fair fight. Infants under one had pneumococcal meningitis rates of about 10 cases per 100,000, the highest of any age group. Adults who got pneumococcal meningitis died about 14% of the time even with modern care. The bug caused more than half of all bacterial meningitis in the United States, roughly 2,000 cases every year.The reason your Facebook cousin has never heard of any of this is that a vaccine came along and made pneumococcus boring. This is that story.

Robert Austrian, Who Refused to Let Penicillin Take a Victory Lap

The hero of Act One is Robert Austrian, a University of Pennsylvania physician who noticed something nobody wanted to notice: penicillin, the miracle drug, wasn’t actually saving people from pneumococcus fast enough. In his landmark study with Jerome Gold, patients with pneumococcal pneumonia kept dying in the first 96 hours of treatment no matter how much penicillin you gave them (PMC Musher et al., 2022).

The bug was faster than the drug

Austrian’s takeaway was radical for the 1960s: stop waiting for people to get sick, and just vaccinate. He then spent the next two decades being professionally annoying about it, which is how he ultimately got the FDA to license a 14-valent polysaccharide vaccine in 1977 and the 23-valent PPSV23 in 1983.

There was one giant problem. Polysaccharide vaccines don’t work in babies and toddlers, the exact group getting the meningitis. You could vaccinate a 60 year old accountant all day long. You could not protect a nine month old. Which meant the kids kept dying while the grown-ups got their shots.

Rachel Schneerson, and the Chemistry Trick That Changed Everything

The fix came from a completely different disease. In 1980, Rachel Schneerson and John Robbins at the NIH figured out that if you chemically glue, “conjugate,” a sugar antigen onto a protein carrier, suddenly the baby immune system understands what it’s looking at (PMC Musher et al., 2022). They proved it with Haemophilus influenzae type b, and within a few years, Hib meningitis, once one of the most common causes of acquired mental disability in American children, was essentially gone.

That was the template. Take the same trick, apply it to pneumococcus. The protein of choice: CRM197, a nontoxic, mutated version of diphtheria toxin. Yes, we teach the baby’s immune system by handing it a decaffeinated diphtheria molecule with pneumococcal sugars stuck to it. Science is not always elegant.

Wyeth Builds Prevnar and the Kaiser Trial Ends the Argument

Investigators at Wyeth picked the seven pneumococcal serotypes that were causing most invasive disease in American kids, conjugated each one to CRM197, and produced Prevnar 7. Then they ran an actually enormous randomized trial. 37,868 infants in the Kaiser Permanente system were randomized to PCV7 or a meningococcal placebo. (Share with your friends who say no childhood vaccines were studied before use).

The results were absurd (PMC — Musher et al., 2022): Type-specific efficacy against invasive pneumococcal disease: greater than 97%.Reduction in pneumococcal meningitis in fully vaccinated infants: greater than 95%.20% fewer chest X-ray confirmed pneumonias (CDC Pink Book). 7% fewer episodes of acute otitis media (unimpressive-sounding until you remember 5 million cases per year is the denominator). 20% fewer tympanostomy tube placements, which is to say, a lot of toddlers in 2001 did not have to be strapped to an OR table so an ENT could put grommets in their eardrums.

The FDA licensed Prevnar 7 in 2000. Within a decade, invasive pneumococcal disease from the seven PCV7 serotypes plus the closely related 6A had dropped 99% in American children.

Serotype Replacement, and Why Prevnar Kept Getting Bigger

Here is the part the “vaccines don’t work” crowd loves to misread. Pneumococcus has roughly 100 serotypes. Knock out seven, and the other 93 notice the vacancy. One serotype in particular, 19A, aggressively filled the niche and started causing invasive disease and antibiotic resistant ear infections. The response was not to give up. It was to make a bigger vaccine.

Prevnar 13 was licensed in 2010, adding serotypes 1, 3, 5, 6A, 7F, and 19A. Invasive pneumococcal disease from PCV13 serotypes then dropped another 90% in American children, and critically, the decline was not offset by an increase in non-vaccine strains (CDC Pink Book). Then came the flex: because vaccinated kids stop carrying pneumococcus in their noses, they stopped giving it to grandma. Adults 65 and older saw a greater than 60% drop in invasive pneumococcal disease from PCV13 serotypes without ever being vaccinated themselves. Grandma got herd immunity from a two-year-old. Say thank you.

PCV15 (2021) and PCV20 (2022 for adults, expanded to children after) piled on more serotypes, so today a fully vaccinated American toddler is protected against 20 of the meanest strains circulating.

What Prevnar Actually Prevents, In Plain English

Pneumococcal meningitis, the one that used to permanently deafen or brain damage the survivors. Down more than 95% for covered serotypes.

Bacteremia and sepsis, the “my previously healthy toddler is suddenly septic” phone call. Nearly eliminated for covered serotypes.

Pneumonia, the leading bacterial cause of pediatric pneumonia. Chest X-ray confirmed cases down about 20%, and pneumococcal pneumonia hospitalizations across all ages dramatically reduced from the pre-vaccine baseline of over 150,000 a year.

Ear infections, the tiny tyrants funding your pediatrician’s boat. Fewer episodes, fewer ear tubes, less amoxicillin, fewer sleepless nights, fewer ruptured eardrums, fewer of those grim conversations about mastoiditis.

The Fine Print, Because Sarcasm Requires Accuracy

Prevnar is not a force field. A fully vaccinated child can, very rarely, still get pneumococcal meningitis, pneumonia, or an ear infection, usually from a serotype not in the vaccine, or from bad luck, or from the roughly 3% of vaccine failures that any 97% intervention leaves on the table. A 97% reduction is not 100%, a mathematical fact that will nonetheless be presented as a smoking gun by someone in your comments section who took ivermectin for a head cold.

The correct comparison is not “vaccinated kid who got sick” vs. “unvaccinated kid who didn’t.” The correct comparison is 17,000 invasive cases and 200 dead children per year vs. now. That is the ledger. Everything else is vibes.

The Moral, With Names Attached

The vaccine that gutted pneumococcus in American children was built on a chemistry insight from Rachel Schneerson and John Robbins at the NIH, powered by the stubbornness of Robert Austrian at Penn, engineered by the team at Wyeth, and validated in a Kaiser Permanente trial of nearly 38,000 babies whose parents said yes. It was recommended by ACIP, added to the childhood schedule in 2000, upgraded in 2010, and upgraded again in the 2020s.

It has prevented, conservatively, hundreds of thousands of American cases of invasive pneumococcal disease, tens of thousands of hospitalizations, thousands of dead children, and roughly a shipping-container’s worth of ear tubes.

Pneumococcus spent 400 years running unopposed. Then a chemistry trick from a Hib project, a diphtheria toxin missing its business end, and a very persistent professor from Philadelphia beat it senseless in about twenty years.

Boost your kids on schedule. Boost the adults who need it. And when someone tells you Prevnar “doesn’t really do anything,” ask them what they think happened to the other 5 million ear infections. Pediatricians have been vaccinating ourselves out of business!!

Sources:

Musher DM, Anderson R, Feldman C. The remarkable history of pneumococcal vaccination. Pneumonia (Nathan). 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9509586/

Centers for Disease Control and Prevention. Chapter 17: Pneumococcal Disease — Pink Book. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-17-pneumococcal-disease.html

RIVM. Higher-valent pneumococcal vaccines for children — 2024 report. https://www.rivm.nl/bibliotheek/rapporten/2024-0181.pdf


Discover more from The Unfiltered Pediatrician

Subscribe to get the latest posts sent to your email.

Share This Post: